MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202527093220 A) filed by Zydus Lifesciences Limited on September 29, 2025, for Treatment For Inflammatory Bowel Disease.
Inventors include Agarwal, Sameer; Chatterjee, Abhijit; Jain, Mukul; Sharma, Rajiv; and Parmar, Deven V. Number.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to the development of therapeutic compound for the treatment of inflammatory bowel diseases. Specifically, the present invention provides an NLRP3 inhibitor or its pharmaceutically acceptable salt or suitable composition useful in the treatment of inflammatory bowel diseases. These severe and persistent illnesses include Crohn's disease and ulcerative colitis, lymphocytic colitis, microscopic colitis, collagenous colitis, autoimmune enteropathy, allergic gastrointestinal disease, eosinophilic gastrointestinal disease and other related forms of disorders.
Disclaimer: Curated by HT Syndication.
